Advocating for cervical cancer prevention

Area of Science:

• Public Health
• Oncology
• Health Policy

Background:

• Cervical cancer poses a significant global health challenge, disproportionately affecting women in developing countries.
• A lack of awareness and political will hinders effective cervical cancer prevention efforts in many regions.
• Advocacy informed by research and program findings is essential for policy and program support.

Purpose of the Study:

• To highlight the importance of evidence-based advocacy in cervical cancer prevention.
• To demonstrate how advocacy can mobilize resources and stakeholders for prevention programs.
• To underscore the role of advocacy in the adoption of new screening, treatment, and vaccine technologies.

Main Methods:

• The Alliance for Cervical Cancer Prevention (ACCP) employed multi-level advocacy (international, regional, national, local).
• Efforts focused on raising awareness, understanding the problem, and promoting workable solutions.
• ACCP engaged funders, governments, and local stakeholders to ensure program success.

Main Results:

• ACCP's experience illustrates the critical role of evidence-based advocacy.
• Advocacy efforts successfully galvanized attention and action from various stakeholders.
• The study emphasizes the link between advocacy and the success of cervical cancer prevention programs.

Conclusions:

• Evidence-based advocacy is a key driver for the success of cervical cancer prevention initiatives.
• Sustained advocacy is vital for implementing and scaling up effective prevention strategies, including new technologies like HPV vaccines.
• Addressing the cervical cancer burden necessitates a combination of research, policy, and dedicated advocacy efforts.